These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 30550614)

  • 1. Inhibition of Diabetes-Induced Lysyl Oxidase Overexpression Prevents Retinal Vascular Lesions Associated With Diabetic Retinopathy.
    Song B; Kim D; Nguyen NH; Roy S
    Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5965-5972. PubMed ID: 30550614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased lysyl oxidase level protects against development of retinal vascular lesions in diabetic retinopathy.
    Kim D; Mecham RP; Nguyen NH; Roy S
    Exp Eye Res; 2019 Jul; 184():221-226. PubMed ID: 31022398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of Lysyl Oxidase Protects Retinal Endothelial Cells From High Glucose-Induced Apoptosis.
    Kim D; Mecham RP; Trackman PC; Roy S
    Invest Ophthalmol Vis Sci; 2017 May; 58(5):2725-2731. PubMed ID: 28538980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of Connexin 43 promotes vascular cell loss and excess permeability associated with the development of vascular lesions in the diabetic retina.
    Tien T; Muto T; Barrette K; Challyandra L; Roy S
    Mol Vis; 2014; 20():732-41. PubMed ID: 24940027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of D-amino acid oxidase prevents retinal neurovascular pathologies in diabetic rats.
    Jiang H; Zhang H; Jiang X; Wu S
    Diabetologia; 2021 Mar; 64(3):693-706. PubMed ID: 33319325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.
    Zhang J; Wu Y; Jin Y; Ji F; Sinclair SH; Luo Y; Xu G; Lu L; Dai W; Yanoff M; Li W; Xu GT
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):732-42. PubMed ID: 18235022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of High Glucose-Induced Lysyl Oxidase Propeptide on Retinal Endothelial Cell Survival: Implications for Diabetic Retinopathy.
    Kim D; Lee D; Trackman PC; Roy S
    Am J Pathol; 2019 Oct; 189(10):1945-1952. PubMed ID: 31537300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
    Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced connexin 43 expression and its effect on the development of vascular lesions in retinas of diabetic mice.
    Bobbie MW; Roy S; Trudeau K; Munger SJ; Simon AM; Roy S
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3758-63. PubMed ID: 20130277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging increases retinal vascular lesions characteristic of early diabetic retinopathy.
    Roy S; Tonkiss J; Roy S
    Biogerontology; 2010 Aug; 11(4):447-55. PubMed ID: 20119717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normalization of retinal vascular permeability in experimental diabetes with genistein.
    Nakajima M; Cooney MJ; Tu AH; Chang KY; Cao J; Ando A; An GJ; Melia M; de Juan E
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2110-4. PubMed ID: 11481279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol blocks diabetes-induced early vascular lesions and vascular endothelial growth factor induction in mouse retinas.
    Kim YH; Kim YS; Roh GS; Choi WS; Cho GJ
    Acta Ophthalmol; 2012 Feb; 90(1):e31-7. PubMed ID: 21914146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylglyoxal induces hyperpermeability of the blood-retinal barrier via the loss of tight junction proteins and the activation of matrix metalloproteinases.
    Kim J; Kim CS; Lee YM; Jo K; Shin SD; Kim JS
    Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):691-7. PubMed ID: 22249316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High glucose increases lysyl oxidase expression and activity in retinal endothelial cells: mechanism for compromised extracellular matrix barrier function.
    Chronopoulos A; Tang A; Beglova E; Trackman PC; Roy S
    Diabetes; 2010 Dec; 59(12):3159-66. PubMed ID: 20823103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A long-term siRNA strategy regulates fibronectin overexpression and improves vascular lesions in retinas of diabetic rats.
    Roy S; Nasser S; Yee M; Graves DT; Roy S
    Mol Vis; 2011; 17():3166-74. PubMed ID: 22171163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
    Skondra D; Noda K; Almulki L; Tayyari F; Frimmel S; Nakazawa T; Kim IK; Zandi S; Thomas KL; Miller JW; Gragoudas ES; Hafezi-Moghadam A
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):726-31. PubMed ID: 18235021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF164 is proinflammatory in the diabetic retina.
    Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of reduced Connexin 43 expression with retinal vascular lesions in human diabetic retinopathy.
    Tien T; Muto T; Zhang J; Sohn EH; Mullins RF; Roy S
    Exp Eye Res; 2016 May; 146():103-106. PubMed ID: 26738943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats.
    Mitsuhashi J; Morikawa S; Shimizu K; Ezaki T; Yasuda Y; Hori S
    Exp Eye Res; 2013 Jan; 106():64-73. PubMed ID: 23178551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cKit Inhibitor, Masitinib, Prevents Diabetes-Induced Retinal Vascular Leakage.
    Kim SR; Im JE; Jeong JH; Kim JY; Kim JT; Woo SJ; Sung JH; Park SG; Suh W
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1201-6. PubMed ID: 26978025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.